ScreenerHero

HNSA Hansa Biopharma AB (publ)

STO · SE · Healthcare · Biotechnology · hansabiopharma.com
33.84SEK+1.87%Mkt Cap: 322.83M $P/E: —

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap322.83M USD
Enterprise Value368.98M USD
Revenue (TTM)18.12M USD
Gross Profit13.27M USD
Net Income (TTM)-51.09M USD
Revenue/Share1.94 SEK
Last Price33.84 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees131
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0002148817
Valuation
P/E (Trailing)—
P/E (Forward)-4.50
PEG—
EV/EBITDA-6.76
EV/Revenue20.36
P/S17.47
P/B-6.49
EPS (TTM)-7.86
EPS (Forward)-7.37
52W Range
23.5242% of range48.22
52W High48.22 SEK
52W Low23.52 SEK
Profitability
Gross Margin62.41%
Oper. Margin-334.87%
EBITDA Margin0.00%
Profit Margin-240.30%
ROE600.18%
ROA-45.78%
Growth
Revenue Growth-2.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-52.53M USD
CapEx (TTM)—
FCF Margin-141.70%
FCF Yield-7.95%
Net Debt46.01M USD
Net Debt/EBITDA-0.84
Balance Sheet
Debt/Equity-10.55
Current Ratio1.25
Quick Ratio1.23
Book Value/Sh-5.11 SEK
Cash/Share5.43 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)73.00 SEK
Upside (mean)+115.7%
Target Range36.00 SEK – 103.00 SEK
36.00+115.7% to mean103.00
# Analysts8
Ownership
Shares Out.99.73M
Float65.75M
Insiders5.72%
Institutions48.60%
Technical
SMA 5039.09 (-13.4%)
SMA 20034.05 (-0.6%)
Beta1.60
S&P 52W Chg14.58%
Avg Vol (30d)593.33K
Avg Vol (10d)712.02K
Technical Indicators
RSI (14)39.5
MACD-1.9607
MACD Signal-1.7802
MACD Hist.-0.1805
BB Upper42.85 SEK
BB Middle36.04 SEK
BB Lower29.22 SEK
BB Width37.81%
ATR (14)1.775 SEK
Vol Ratio (20d)0.60x